These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Antineutrophil cytoplasmic antibodies in Japanese patients with inflammatory bowel disease: prevalence and recognition of putative antigens. Sugi K; Saitoh O; Matsuse R; Tabata K; Uchida K; Kojima K; Nakagawa K; Tanaka S; Teranishi T; Hirata I; Katsu K Am J Gastroenterol; 1999 May; 94(5):1304-12. PubMed ID: 10235211 [TBL] [Abstract][Full Text] [Related]
5. Prevalence and diagnostic role of antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Bansi DS; Chapman RW; Fleming KA Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):881-5. PubMed ID: 8889455 [TBL] [Abstract][Full Text] [Related]
6. Antineutrophil cytoplasmic antibodies in Estonian patients with inflammatory bowel disease. Prevalence and diagnostic role. Kull K; Salupere R; Uibo R; Ots M; Salupere V Hepatogastroenterology; 1998; 45(24):2132-7. PubMed ID: 9951879 [TBL] [Abstract][Full Text] [Related]
7. A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease. Rump JA; Schölmerich J; Gross V; Roth M; Helfesrieder R; Rautmann A; Lüdemann J; Gross WL; Peter HH Immunobiology; 1990 Nov; 181(4-5):406-13. PubMed ID: 2099908 [TBL] [Abstract][Full Text] [Related]
8. Anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease: do they recognize different subsets of a heterogeneous disease? Castellino F; Rosina F; Bansi DS; Bauducci M; Touscoz GA; Giorda L; Borghesio E; Bessone MP; Astegiano M; Musso A Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):859-64. PubMed ID: 8574718 [TBL] [Abstract][Full Text] [Related]
9. [antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease]. Papo M; Quer JC; Pastor RM; García-Pardo G; Olona M; Prats E; Mirapeix E; Rodríguez R; Richart C Med Clin (Barc); 1998 Jan; 110(1):11-5. PubMed ID: 9527980 [TBL] [Abstract][Full Text] [Related]
10. Relationship between ANCA and clinical activity in inflammatory bowel disease: variation in prevalence of ANCA and evidence of heterogeneity. Abad E; Tural C; Mirapeix E; Cuxart A J Autoimmun; 1997 Apr; 10(2):175-80. PubMed ID: 9185879 [TBL] [Abstract][Full Text] [Related]
11. Phagocytosis, killing, lymphocyte-mediated antibacterial activity, serum autoantibodies, and plasma endotoxins in inflammatory bowel disease. Caradonna L; Amati L; Lella P; Jirillo E; Caccavo D Am J Gastroenterol; 2000 Jun; 95(6):1495-502. PubMed ID: 10894586 [TBL] [Abstract][Full Text] [Related]
12. Anti-neutrophil cytoplasmic antibodies in chronic inflammatory bowel disease. Prevalence and diagnostic role. Hertervig E; Wieslander J; Johansson C; Wiik A; Nilsson A Scand J Gastroenterol; 1995 Jul; 30(7):693-8. PubMed ID: 7481534 [TBL] [Abstract][Full Text] [Related]
13. Antineutrophil cytoplasmic antibodies in relatives of patients with inflammatory bowel disease. Papo M; Quer JC; Pastor RM; García-Pardo G; Prats E; Mirapeix E; Rodríguez R; Richart C Am J Gastroenterol; 1996 Aug; 91(8):1512-5. PubMed ID: 8759652 [TBL] [Abstract][Full Text] [Related]
14. [Assessment of usefulness of anti-Saccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies in patients with unspecific inflammatory bowel diseases]. Mokrowiecka A; Gasiorowska A; Małecka-Panas E Pol Merkur Lekarski; 2004; 17 Suppl 1():22-6. PubMed ID: 15603341 [TBL] [Abstract][Full Text] [Related]
15. Low prevalence of anti-neutrophil cytoplasmic antibodies in ulcerative colitis patients with long-term remission. Lindgren S; Florén CH; Lindhagen T; Starck M; Stewenius J; Nässberger L Eur J Gastroenterol Hepatol; 1995 Jun; 7(6):563-8. PubMed ID: 7552641 [TBL] [Abstract][Full Text] [Related]
16. Atypical antineutrophil cytoplasmic antibodies with perinuclear fluorescence in chronic inflammatory bowel diseases and hepatobiliary disorders colocalize with nuclear lamina proteins. Terjung B; Herzog V; Worman HJ; Gestmann I; Bauer C; Sauerbruch T; Spengler U Hepatology; 1998 Aug; 28(2):332-40. PubMed ID: 9695994 [TBL] [Abstract][Full Text] [Related]
17. Serum antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical, and surgical treatment. Oudkerk Pool M; Ellerbroek PM; Ridwan BU; Goldschmeding R; von Blomberg BM; Peña AS; Dolman KM; Bril H; Dekker W; Nauta JJ Gut; 1993 Jan; 34(1):46-50. PubMed ID: 8432451 [TBL] [Abstract][Full Text] [Related]
18. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype. Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007 [TBL] [Abstract][Full Text] [Related]
19. [Frequency and clinical associations of antineutrophil cytoplasmic antibodies. A regional experience]. Defendenti C; Spina MF; Grosso S; Longo M; Bollani S; Cereda A; Saibeni S; Guercilena G; Atzeni F; Sarzi-Puttini P Recenti Prog Med; 2010 Jan; 101(1):16-26. PubMed ID: 20391682 [TBL] [Abstract][Full Text] [Related]
20. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity. Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]